NCT00052416 2013-06-26Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 1 Completed
NCT00015912 2013-01-25Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Terminated35 enrolled
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled